Alzheimer’s Breakthrough Drugs: Hype, Hope, and Hard Truths
Alzheimer’s Drugs Under Scrutiny: Are They Worth It? The arrival of drugs like donanemab and lecanemab was hailed as a
Continue ReadingJune 18, 2026
Alzheimer’s Drugs Under Scrutiny: Are They Worth It? The arrival of drugs like donanemab and lecanemab was hailed as a
Continue ReadingYale Researchers Discover Link Between COVID Spike Protein and Amyloid Beta Accumulation A groundbreaking study from Yale University has uncovered
Continue ReadingNew Hope for Alzheimer’s: Protecting Memory Through the Blood-Brain Barrier Alzheimer’s disease, a condition affecting millions worldwide, has long been
Continue ReadingAlzheimer’s disease has long been considered a neurodegenerative disorder, but recent research suggests it may have infectious origins. Scientists have
Continue ReadingEncephalitis, a severe inflammation of the brain often caused by viral infections, has officially been recognized as a global health
Continue Reading